Search research articles
Contact Us
Filters
Showing results (301-310 of 345) with videos related to
Page
of 35
Sort By:
Prostate Cancer and Prostatic Diseases
|
June 7, 2017
Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
M E O'Callaghan, E Raymond, J Campbell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
E Raymond, M Fabbro, V Boige, et al.
Investigational New Drugs
|
September 18, 1998
Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies
H A Burris, E Raymond, A Awada, et al.
Macromolecular Rapid Communications
|
September 25, 2020
Multifunctional Synthetic Protein Nanoparticles via Reactive Electrojetting
Daniel F Quevedo, Nahal Habibi, Jason V Gregory, et al.
Anti-Cancer Drug Design
|
January 8, 2000
Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos
E Izbicka, D Nishioka, V Marcell, et al.
The American Journal of Cardiology
|
July 15, 1997
Intravascular ultrasound assessment of the prevalence and causes of angiographic "haziness" following high-pressure coronary stenting
K M Ziada, E M Tuzcu, A C De Franco, et al.
Soft Matter
|
March 20, 2015
Responsive organogels formed by supramolecular self assembly of PEG-<i>block</i>-allyl-functionalized racemic polypeptides into β-sheet-driven polymeric ribbons
Jiong Zou, Fuwu Zhang, Yingchao Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer
E Raymond, W W ten Bokkel Huinink, J Taïeb, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 18, 2001
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable
P J Casterella, D J Kereiakes, S R Steinhubl, et al.
British Journal of Clinical Pharmacology
|
November 26, 2002
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)
Charlotte van Kesteren, R A A Mathôt, E Raymond, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 345) with videos related to
Sort By:
Page
of 35
Prostate Cancer and Prostatic Diseases
|
June 7, 2017
Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
M E O'Callaghan, E Raymond, J Campbell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
E Raymond, M Fabbro, V Boige, et al.
Investigational New Drugs
|
September 18, 1998
Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies
H A Burris, E Raymond, A Awada, et al.
Macromolecular Rapid Communications
|
September 25, 2020
Multifunctional Synthetic Protein Nanoparticles via Reactive Electrojetting
Daniel F Quevedo, Nahal Habibi, Jason V Gregory, et al.
Anti-Cancer Drug Design
|
January 8, 2000
Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos
E Izbicka, D Nishioka, V Marcell, et al.
The American Journal of Cardiology
|
July 15, 1997
Intravascular ultrasound assessment of the prevalence and causes of angiographic "haziness" following high-pressure coronary stenting
K M Ziada, E M Tuzcu, A C De Franco, et al.
Soft Matter
|
March 20, 2015
Responsive organogels formed by supramolecular self assembly of PEG-<i>block</i>-allyl-functionalized racemic polypeptides into β-sheet-driven polymeric ribbons
Jiong Zou, Fuwu Zhang, Yingchao Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer
E Raymond, W W ten Bokkel Huinink, J Taïeb, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 18, 2001
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable
P J Casterella, D J Kereiakes, S R Steinhubl, et al.
British Journal of Clinical Pharmacology
|
November 26, 2002
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide)
Charlotte van Kesteren, R A A Mathôt, E Raymond, et al.
Page
of 35